BIOCYTOGEN-B (02315.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec5

Biosceptre and Partner Ideaya Obtain FDA Approval to Advance IDE034 Phase I Clinical Trial for B7H3/PTK7 Bispecific Antibody Drug Conjugate

01:02

Nov19

Biosettia Biotech B (02315.HK) Plans to Issue 47.5 Million New A-Share Stocks

23:42

Biosettia-B reports net profit of 114 million yuan for Q1-Q3 2025, reversing previous loss

23:32

Nov6

Huafu Securities Gives Buy Rating to Biocytogen-B Based on Its Future Prospects

07:37

Sep23

Biosyntech Grants IDE034 Project to IDEAYA Biosciences

08:07

Sep18

Biosetum Reports Profit in Q2 2025 Financial Report

02:36

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 339.83 M, Net Income 26.27 M, EPS 0.0662

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 303.17 M, Net Income 44.8 M, EPS 0.1126

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 220.55 M, Net Income -27.22 M, EPS -0.0683

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More